financetom
Business
financetom
/
Business
/
IndiGo warns of weakening market after “unusual” October
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IndiGo warns of weakening market after “unusual” October
Oct 24, 2019 10:48 AM

IndiGo has warned of sustained weakness in the market after “unusual” fares in the strong month of October, which has two important festivals of Dusshera and Diwali.

“July and August were strong months. September, we started seeing some weakening but then September is always weak. And now October is typically a very strong month with two big Indian holidays-Dusshera and Diwali. Generally, we don’t see anyone coming out with sales during this period because demand is so strong. This October was unusual,” Chief Executive Officer Ronojoy Dutta said in the post-earnings conference call.

ALSO READ:

Indigo's Q2 consolidated net loss widens to Rs 1,031 while revenue rises 31% YoY

Dutta added that a strong month like October does not ideally witness airlines offering discounts on fares but two players offering discounted fares in the middle of festivals indicate that the market has slowed down.

“In the middle of Dusshera, we had one competitor coming for sale and now the second competitor comes with the sale. That says there is weakness otherwise why will these competitors come with the sale,” Dutta added.

ALSO READ: IndiGo postpones launch of much-hyped flights to London

Full-service carrier Vistara had announced a special 48-hour sale starting October 10. The sale was for travel between Oct 10 and Mar 28. GoAir had also announced pre-Diwali 'super saver fares' deal for 24 hours on Oct 17. This was valid for travel between Oct 20 and Oct 23.

Discounted fares in the festival season have also forced IndiGo to reduce its growth expectations for the current quarter.

“Revenue during the festive season was somewhat subdued. We are expecting a flattish year-on-year unit revenue growth for this quarter. We are still early in the quarter and things will of course change,” Dutta added.

First Published:Oct 24, 2019 7:48 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Norwegian Cruise Line Holdings Insider Bought Shares Worth $252,021, According to a Recent SEC Filing
Norwegian Cruise Line Holdings Insider Bought Shares Worth $252,021, According to a Recent SEC Filing
Nov 6, 2025
05:28 PM EST, 11/06/2025 (MT Newswires) -- Jason Montague, Chief Luxury Officer, on November 06, 2025, executed a purchase for 13,400 shares in Norwegian Cruise Line Holdings ( NCLH ) for $252,021. Following the Form 4 filing with the SEC, Montague has control over a total of 65,791 common shares of the company, with 52,391 shares held directly and 13,400...
Broadcast media firm E.W. Scripps Q3 revenue down 
Broadcast media firm E.W. Scripps Q3 revenue down 
Nov 6, 2025
Overview * E.W. Scripps Q3 revenue fell 19% yr/yr, impacted by lower political ad revenue * Net loss attributable to shareholders was $49 mln, impacted by restructuring and financing costs * Connected TV revenue grew 41%, offsetting economic uncertainty in Scripps Networks Outlook * Company expects Q4 Local Media revenue to decline about 30% * Scripps Networks Q4 revenue and...
Beauty Health Q3 revenue down 10.3%, but beats estimates
Beauty Health Q3 revenue down 10.3%, but beats estimates
Nov 6, 2025
Overview * Beauty Health Q3 2025 revenue of $70.7 mln beats analyst expectations * Adjusted EBITDA beat analysts' estimates, reaching $8.9 mln * Net sales declined 10.3% yr/yr due to lower delivery systems and consumables sales Outlook * Beauty Health ( SKIN ) projects 2025 net sales between $293 mln and $300 mln * Company expects 2025 adjusted EBITDA of...
Globus Medical Q3 profit beat estimates on U.S. spine growth
Globus Medical Q3 profit beat estimates on U.S. spine growth
Nov 6, 2025
Overview * Globus Medical ( GMED ) Q3 sales rose 22.9% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, growing 42.6% yr/yr * Company executed $40 mln in share repurchases, totaling $255.5 mln in 2025 Outlook * Company raises 2025 revenue guidance to $2.86-$2.90 bln from $2.80-$2.90 bln * Globus Medical ( GMED ) expects 2025 non-GAAP...
Copyright 2023-2026 - www.financetom.com All Rights Reserved